'Dean of Valuation' Aswath Damodaran is not buying SpaceX: 'Too richly priced'

SpaceX is targeting a $135 IPO price that implies a $1.77 trillion valuation, while Aswath Damodaran values the company at $1.25 trillion to $1.35 trillion. He argues the stock is rich versus fundamentals, with AI/xAI the biggest valuation wild card due to weak unit economics, intense competition, and high capital spending. The piece is commentary on valuation ahead of SpaceX's Nasdaq debut on June 12 rather than a direct operating update.

Analysis

The clearest second-order effect is not on SpaceX itself but on every late-stage private asset now using “category-defining optionality” as a valuation bridge. If this IPO clears near the top of the range, it resets the reference point for AI-adjacent, founder-controlled platforms to argue for scarcity multiples even when current economics are mediocre. That tends to compress the pricing gap between public-market software/AI infrastructure and private-market venture rounds, and it increases the odds of more capital rotating into the handful of public names seen as the closest liquid proxies for frontier tech exposure.

The market’s real mistake would be treating this as a pure IPO event rather than a cross-asset signaling event. A rich debut would likely reinforce appetite for Nasdaq-led growth beta over the next 1-3 months, but it also raises the probability of a post-listing air pocket if the lockup/float dynamic collides with forward revenue skepticism. The more crowded the “Musk premium” becomes, the more vulnerable the trade is to any operational hiccup, especially because the valuation framework depends on execution staying pristine across multiple businesses at once.

The contrarian angle is that the market may be underpricing how hard it is to sustain a premium when one segment is being valued on long-duration AI optionality while the other segments are mature enough to invite normal industrial-style scrutiny. If investors start separating high-quality cash generation from speculative growth inside the same security, the implied blended multiple can compress fast. In that scenario, the first beneficiaries are likely the capital-light infrastructure names and exchange/market-venue operators that gain from elevated IPO volume and trading activity, while the losers are later-stage private comps that now have a higher bar to justify their own marks.

Key Decisions for Investors

• NDAQ: Buy 1-3 month calls into the listing week; a successful marquee debut should support IPO activity, trading volumes, and advisory pipelines. Risk/reward is favorable if the deal catalyzes a broader issuance window, with downside limited to a short-lived hype fade.
• IPO / post-listing event trade: Avoid chasing the first print; wait 2-6 weeks for float expansion and any secondary supply. If the stock gaps materially above the indicated range, consider a tactical short via options after the initial squeeze as the market shifts from narrative to cash-flow scrutiny.
• Pair trade: Long NDAQ / short a basket of high-multiple private-market proxy names via liquid public comps. Thesis is that a successful marquee IPO widens the quality gap between assets with real liquidity and those still priced on optionality.
• If you want exposure to the AI premium without single-name binary risk, express it through a basket of profitable Nasdaq-listed AI enablers rather than the IPO itself. Use a 3-6 month horizon; the cleaner earnings base should outperform if the market remains receptive to frontier-tech stories.
• Set a trigger to fade the trade if the debut is followed by 10-15% underperformance versus Nasdaq over 2-4 weeks; that would signal the market is rejecting the premium and would support a rotation back into cash-flow compounders.